A new study has found that a combination of two drugs could enhance the immune system to treat one of the most common types of cancer in the world, bowel cancer. Also known as colorectal cancer, despite its widespread presence, the treatment options for this condition are limited. What the study specifically found was that this procedure could shrink the tumours caused by this condition by around 60%.
What Are The Drugs Involved
The trial involved the use of two immunotherapy drugs, botancilimab and balstilumab. It is a monoclonal antibody that works to stimulate the body's immune system to attack cancer. The study is a rather significant find, as it’s the first time that a consistent and durable response to immunotherapy has been reported in patients with solid MSS mCRC tumours.
The study was divided into several phases for more than 6 months. In the US trial, around around 101 patients with microsatile stable metastatic colorectal (MSS-mCRC) tumours showed a decrease . Around 61% of the patients experienced tumour shrinkage or stabilization after combined treatment with votancilumab and balstilumab. When it comes to downsides, diarrhea and fatigue were found to be the most common side effects or side effects of this drug.
These results are interesting and open to exploration. To date, immunotherapy has not been effective in patients with CNS-mCRC tumors. This study demonstrates the potential of the combination of botenlimab and balstilimab in the treatment of CNS mCRC, providing new hope for people diagnosed with colon cancer.
What Could This Mean For Bowel Cancer Treatment In The Future
The study is currently in the final stages of clinical trials, and the US Food and Drug Administration (FDA) hopes to quickly gain approval for its use because of the importance of this area that affects many people. The efficiency shown demonstrates the potential of botansilimab to contribute to broad antitumor immunity.
All in all, the combination of botensilimab and balstilimab represents a promising new direction in the treatment of colorectal cancer. This breakthrough could improve conditions for many patients worldwide and lights a new hope in the fight against this common disease. The results of this study show the effectiveness of immunotherapy in this field and how its potential to transform cancer treatment can only grow in the years to come.
Credit: iStock
In a landmark judgement, the Supreme Court today allowed passive euthanasia for a 32-year-old man, living in a vegetative state for the last 13 years.
A bench comprising Justice JB Pardiwala and Justice KV Viswanathan allowed the withdrawal of life support for Harish Rana, a resident of Ghaziabad, who has been in a coma and kept alive on tubes for breathing and nutrition after sustaining severe head injuries following a fall from a building in 2013 in Chandigarh.
It is the first known case of a court-ordered passive euthanasia in India, since it was legalised in 2018 and modified in 2023, recognizing the fundamental right to die with dignity.
"Harish Rana, presently aged 32 years, was once a young, bright boy. He met with a tragic life-altering accident after a fall from the fourth floor of his paying guest accommodation. His brain injury left him in a condition of Persistent Vegetative State (PSV) with 100 percent quadraplegia... Medical reports show that his medical condition has not improved in the past 13 years," LiveLaw quoted the bench as saying.
The Court noted that the continuation of his treatment -- Clinically Administered Nutrition (CAN) via surgically installed PEG tubes -- can just prolong his biological existence but will not lead to any therapeutic improvement.
Harish was a BTech student in Chandigarh who suffered severe traumatic brain injury after falling from the fourth floor of his paying guest accommodation in August 2013.
Since then, he has remained bedridden and dependent on others for all activities of daily life.
Harish's father, the petitioner, first approached the Delhi High Court in 2024, seeking permission for passive euthanasia, but was rejected as the patient was not terminally ill.
The same year, the petitioner knocked on the doors of the Supreme Court, which, though it refused to entertain the plea, directed the Uttar Pradesh government to bear the treatment expenses.
In 2025, the petitioner filed a miscellaneous application in the Supreme Court, noting that Harish's condition had no scope for improvement.
The Court then directed the constitution of a Primary Medical Board led by the District Hospital in Noida to examine his health, as well as a Secondary Medical Board constituted by the All India Institute of Medical Sciences (AIIMS).
After perusing the report, Justice Pardiwala remarked that it's a "sad report" and the man can't continue to live like this. Before passing the final order, the Court met the parents, LiveLaw reported.
The Court has asked AIIMS to provide palliative care, so that the withdrawal of CAN can be given effect to.
To maintain the dignity of death, the apex Court said that the life support must be withdrawn with a tailored plan.
In 2018, a five-judge Constitution Bench had recognized and given sanction for passive euthanasia, and living will/advance directives.
Later in 2023, the SC modified the guidelines, noting that withdrawal of life support is permissible only after the approval of the Primary and Secondary Medical Boards.
With the Harish Rana judgment, the apex Court today clarified how passive euthanasia should be applied in cases where a patient’s life is being supported by feeding tubes.
The top Court waived off the reconsideration period of 30 days and noted that the medical treatment, including the CAN administered to the patient, can be withdrawn or withheld.
Passive Euthanasia allows a terminally ill or irreversibly comatose patient to die naturally. It involves deliberately withholding or withdrawing life-sustaining treatments (like ventilators, feeding tubes, or medication). It has been legal since 2018, but under strict guidelines.
In Active Euthanasia, patients are administered a lethal injection to cause death. It is illegal in India and considered an offence.
The Aruna Shanbaug case in 2011 opened the door for passive euthanasia in India for the first time.
The top Court rejected euthanasia in the case of Shanbaug, a nurse at Mumbai's KEM hospital who was in a vegetative state for 42 years after an assault in 1973, as the hospital staff who cared for her for decades did not support stopping treatment.
Shanbaug continued to be under care and passed away naturally in 2015
However, in her case, the court made the judgment allowing for passive euthanasia in certain rare situations under strict conditions.
Credit: iStock
In the wake of a shocking incident in Uttar Pradesh’s Kanpur, where two engineers allegedly died within 48 hours of undergoing hair transplant surgery by a dentist, the Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) and the Association of Plastic Surgeons of India (APSI) have pressed the need for stricter rules for aesthetic and hair restoration procedures.
The doctors raised concerns about patient safety and called for ramping up training standards, even as many such cases where unqualified medical practitioners performed aesthetic procedures leading to severe infections, loss of sight, and many complications have been documented from across the country.
Traditionally, these procedures were performed by specialists such as dermatologists and plastic surgeons trained under the regulatory framework of the National Medical Commission (NMC).
However, experts said the issue has become more complicated after the Dental Council of India (DCI) allowed MDS dental surgeons, under provisions of the Dentists Act, 1948, to perform certain aesthetic procedures and hair transplantation.
“Aesthetic procedures and dermatology demand additional training. In addition to the MBBS degree, a dermatologist training program requires three years of residency at a postgraduate level in dermatology at certain accredited medical schools,” Dr Vinay Singh, President IADVL said.
He added that the training also includes a condensed curriculum of various skin ailments, hair problems, and advanced procedures in dermatology.
“Allowing professionals without comprehensive medical training in skin diseases, hair disorders, and surgical complication management to perform such procedures could dilute training standards and increase risks for patients,” warned Dr. Rajat Gupta, Senior Consultant Plastic Surgeon, Delhi.
The experts also pointed out that hair transplant is a modern medical procedure and should only be conducted by Registered Medical Practitioners (RMPs) who are specialized in that area.
Also read: Fact Check: Popular Hair Loss Treatment Ingredient Could Trigger Chest Pain
Dr. Aditya Aggarwal, Senior Consultant Plastic Surgery, Medicity Medanta Hospital, shared that the surgery requires knowledge regarding the biology of the skin, the disorders of the hair, how to manage infections, and how to manage complications.
The associations urged the government to issue comprehensive guidelines and ensure strict implementation of existing regulations to curb quackery and safeguard public health.
Further, they advised the patients to verify the doctor’s qualifications and registration with the state medical council before undergoing any skin, hair, or cosmetic treatment.
The public must remain alert and avoid falling prey to misleading advertisements or treatments offered by unlicensed practitioners, the experts said.
Credit: iStock
About 6 million people in India's capital city are living with several vision problems, such as poor distance vision or near vision, according to a recent study by doctors at All India Institute of Medical Sciences (AIIMS), New Delhi.
The study, Dr. Rajendra Prasad Centre for Ophthalmic Sciences at AIIMS, and submitted to the World Health Organization (WHO), also flagged major gaps in eye care services in Delhi, the Times of India reported.
An estimated one-third of the population in the national capital was identified with refractive errors or presbyopia -- conditions that can usually be corrected with a pair of glasses. Globally, 826 million people suffer from presbyopia.
About 70 percent of older adults in the capital city were identified with the problem.
Alarmingly, about 13.1 percent school-going children had refractive errors, Dr. Praveen Vashist, professor and head of community ophthalmology at AIIMS, was quoted as saying.
The study showed a lack of access to vision correction. While just 60 percent of people needing distance vision correction could access care, those with near vision correction could access care in over 47 percent of cases.
Further, the doctors found:
But Dr. Vashisth noted that Delhi currently has only 1,085 ophthalmologists and approximately 489 optometrists.
Further, only 50 community-level vision centers, out of the has 249 eye care institutions in the city were found to be functioning. Moreover, only about 25 percent of children were receiving free spectacles through public health initiatives.
According to the World Health Organization (WHO), at least 2.2 billion people worldwide have near or distance vision impairment. Of these, at least 1 billion cases could be prevented with increased access to eyeglasses and cataract surgeries
The WHO identifies refractive errors and cataracts as the leading causes of vision impairment and blindness.
Vision loss can affect people of all ages; however, most people with vision impairment and blindness are over the age of 50.
Here's how to maintain a healthy vision:
© 2024 Bennett, Coleman & Company Limited